Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systane vs. Vismed in Dry Eye
NCT00493662Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of polyethylene glycol 400 and propylene glycol in dry eye syndrome (DED) (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Standardized Evaluation of Symptoms of Dryness. Status: completed.
02
Drugs
polyethylene glycol 400propylene glycol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00493662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00493662.